Pre-randomisation | Baseline Assessment | Intervention period (0–14 weeks) | 14-week Assessment | 16–18 weeks after randomisation | |
---|---|---|---|---|---|
Enrolment | |||||
Potential participant identification and screening | X | ||||
Provision of PIS | X | ||||
Eligibility assessment | X | ||||
Informed consent | X | ||||
Assessment | |||||
Demographics | X | X | |||
Nottingham Extended Activities of Daily Life Scale (NEADL) | X | X | |||
EuroQol EQ-5D-5L | X | X | |||
Average, worst and walking hip/knee pain (0–10 NRS) | X | X | |||
Nordic pain questionnaire | X | X | |||
Geriatric Depression Scale (GDS-15) | X | X | |||
Geriatric Anxiety Scale (GAS10) | X | X | |||
ProFANE self-report of falls and fall related injuries | X | X | |||
Walking confidence: single item from Modified Gait Self-Efficacy Scale | X | X | |||
Short Physical Performance Battery (SPPB) | X | X | |||
Current medications | X | ||||
Attendance-treatment log (TEMPO intervention) | X | ||||
Adherence-home exercise diary (TEMPO intervention) | X | ||||
Adverse events recorded | X | X | |||
Additional treatments received | X | ||||
Postal/phone collection of core outcomes (if required) | X | ||||
Qualitative interviews with sample of participants | X | ||||
Interventions | |||||
Provision of hip/knee OA booklet (usual care) | X | ||||
Referral to TEMPO physiotherapist | X | ||||
TEMPO programme: 4–8 individual sessions with physiotherapist | X |